bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
PATHADD07

Order Name:
Immunohistochemical stain: PgR

 
Useful For:
Qualitative detection of progesterone receptor protein in a diagnostic setting
 
Methodology:
Immunohistochemistry
 
AliasesName:
Progesterone Receptor
 
 
 
Test Code:
PATHADD07

Order Name:
Immunohistochemical stain: PgR

 
Collection Specimen Or Container:
1. Tissue in 10% neutral buffered formalin or 
2. Paraffin embedded tissue block or
3. Unstained positively charged slides as least 2 slides
 
Specimen Testing Type:
1. Tissue in 10% neutral buffered formalin or 
2. Paraffin embedded tissue block or
3. Unstained positively charged slides as least 2 slides
 
Sub Mission Container:
1. Tissue in 10% neutral buffered formalin or 
2. Paraffin embedded tissue block or
3. Unstained positively charged slides as least 2 slides
 
Rejection Criteria:
1. Wet/ frozen tissue Cytology smears 
2. Non formalin fixed tissue 
3. Non paraffin embedded tissue 
4. Non charged slides
 
Specimen Stabillity:
 
Specimen Type Temperature
Tissue 1. Room temperature for Tissue in 10% neutral buffered formalin
2. Room temperature for paraffin embedded tissue block and unstained slide
(Breast tissue should be fixed in formalin for 6-48 hours, not to exceed 72 hours )
 
 
 
Test Code:
PATHADD07

Order Name:
Immunohistochemical stain: PgR

 
Method detail:
Immunohistochemistry
 
Schedule:
Tested daily, at 07:00 am. - 06:00 pm.
 
Turnaround Time:
5-7 days
 
Performing Location:
Surgical Pathology, Laboratory Department Tel.14146
 
Specimen Retention Time:
10 years after final report
 
 
 
Test Code:
PATHADD07

Order Name:
Immunohistochemical stain: PgR

 
 
Clinical Information:
Progesterone receptor is a hormone receptor localized within the nucleus. It is highly expressed in the epithelial cells of the breast and endometrium, and smooth muscle cells of the uterus. This antibody is used along with that for estrogen receptor to assess hormonal responsiveness in breast cancer.
 
Clinical Reference:
1.https://www.mayocliniclabs.com/test-catalog/Clinical+and+Interpretive/70542
(Retrived 29 JAN 19)